Document is current
Any future updates will be listed below
-
Authors
Gomez, Alejandro M. https://orcid.org/0000-0001-6955-5977
Babuadze, George
Plourde-Campagna, Marc-André
Azizi, Hiva
Berger, Alice
Kozak, Robert
de La Vega, Marc-Antoine
XIII, Ara
Naghibosadat, Maedeh
Nepveu-Traversy, Marie-Edith
Ruel, Jean https://orcid.org/0000-0001-6936-4943
Kobinger, Gary P. https://orcid.org/0000-0003-0612-2298
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (OVV-152411, OVV-152411, OVV-152411)
- License Information
-
More Information
Article History
Received: 9 March 2021
Accepted: 24 November 2022
First Online: 22 December 2022
Competing interests
: The authors A.M.G., G.B., M-A.P.C., H.A., A.B., R.K., M.A.D.L.V., A.X., M.N., M-E.N.T. and J.R. declare no competing interests. The authors have no financial conflicts of interest at the time these studies were conducted and this manuscript written. As of August 2022, Gary Kobinger has agreed to be the technical advisor on the commercial development of IONAID to a start-up company registered in Canada in which he owns equity. The company (Inocujet Inc.) has no monetary value at the time of submission.
